
GAMMA III conducts final close on EUR32.6m
Fund
GAMMA capital partners has held the final close of its third fund GAMMA III on EUR32.6m. Structured as a Luxembourg limited partnership (SICAR), the fund was launched in October 2006 with a target of EUR75m and a hard cap of EUR100m. After the previous close was achieved at the end of 2007, gamma had garnered significant interest from a number of investors, which, however, were unwilling to make commitments in the current market turbulences, leading to the final close.
Terms and conditions are described as market standard. Candela Capital is acting as a placing agent to the fund, while Oostvogels Pfister Feyten provided legal advice.
Investors
The majority of existing LPs from gamma capital partners' previous two funds have re-upped with larger ticket sizes. The minimum investment for institutional investors is EUR1m and EUR125,000 for private investors.
Investments
GAMMA III takes minority stakes in 12-20 fast-growing technology companies in the areas of information & communication technologies (ICT), electronics, life sciences with focus on medtech, specialty and materials, and renewable energy/cleantech. Equity investments range from EUR500,000-4m.
The fund's geographical focus is diversified, with two-thirds of the fund to be invested in the DACH region, while the remainder reserved for investments in the Czech Republic, Slovakia, Hungary and Slovenia.
GAMMA III has already invested in six companies, such as Liechtenstein-based biotechnology company Pantec Biosolutions, when it led a CHF 6.3m series-A round (February 2008, page 30).
People
The fund is managed by the three partners: Oliver Grabherr, Klaus Matzka and Burkhard Feurstein, who are supported by five investment professionals.
Name: GAMMA III
Final close: EUR32.6m
Focus: Early-stage, DACH, CEE
Contact: Klaus Matzka
Address: Reisnerstrasse 40/3
A-1030 Vienna
Austria
Tel: +43 1 5131072 0
Fax: +43 1 5131072 200
k.matzka@gamma-capital.com
www.gamma-capital.com
Advisers: Candela Capital (Placing agent)
Oostvogels Pfister Feyten (Legal).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater